Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction.
Journal Information
Full Title: Aliment Pharmacol Ther
Abbreviation: Aliment Pharmacol Ther
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of personal interests : PV: None; MG: None; LM: None; GDC: None; FBS: None; ST: None; MF: None; AB: None; MB: None; VS: None; RP: has received lectures fees from Alfasigma; consulting for Reckitt Benckiser and Sofar. CPG: Consulting for Medtronic, Diversatek, Takeda, Ironwood, Isothrive, Quintiles, and Johnson and Johnson; EVS: has received lecture or consultancy fees from Abbvie, Alfasigma, Amgen, Aurora Pharma, Bristol‐Myers Squibb, EG Stada Group, Fresenius Kabi, Grifols, Janssen, Johnson&Johnson, Innovamedica, Malesci, Medtronic, Merck & Co, Reckitt Benckiser, Sandoz, Shire, SILA, Sofar, Takeda, Unifarco; NdB: Lectures fees from Malesci and Reckitt Benckiser. Open Access Funding provided by Universita degli Studi di Pisa within the CRUI‐CARE Agreement."
"FUNDING INFORMATION None."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025